Literature DB >> 21215526

Stress buffering effects of oxytocin on HIV status in low-income ethnic minority women.

Erin M Fekete1, Michael H Antoni, Corina Lopez, Armando J Mendez, Angela Szeto, Mary Ann Fletcher, Nancy Klimas, Mahendra Kumar, Neil Schneiderman.   

Abstract

BACKGROUND: Elevated perceptions of psychosocial stress and stressful life events are linked to faster disease progression in individuals living with HIV and these associations may be stronger for women from ethnic minority populations. Levels of neurohormones such as oxytocin (OT), cortisol, and norepinephrine (NE) have been shown to influence the effects of psychosocial stress in different populations. Understanding how intrinsic neuroendocrine substances moderate the effects of stressors in minority women living with HIV (WLWH) may pave the way for interventions to improve disease management.
METHODS: We examined circulating levels of plasma OT as a moderator of the effects of stress on disease status (viral load, CD4+ cell count) in 71 low-income ethnic minority WLWH.
RESULTS: At low levels of OT, there was an inverse association between stress and CD4+ cell counts. Counter-intuitively, at high levels of OT there was a positive association between stress and CD4+ cell counts. This pattern was unrelated to women's viral load. Other neuroendocrine hormones known to down-regulate the immune system (cortisol, norepinephrine) did not mediate the effects of OT and stress on immune status.
CONCLUSIONS: OT may have stress buffering effects on some immune parameters and possibly health status in low income ethnic minority WLWH reporting elevated stress.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21215526      PMCID: PMC3094741          DOI: 10.1016/j.psyneuen.2010.12.003

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  49 in total

Review 1.  Biobehavioral responses to stress in females: tend-and-befriend, not fight-or-flight.

Authors:  S E Taylor; L C Klein; B P Lewis; T L Gruenewald; R A Gurung; J A Updegraff
Journal:  Psychol Rev       Date:  2000-07       Impact factor: 8.934

Review 2.  Post-hoc probing of significant moderational and mediational effects in studies of pediatric populations.

Authors:  Grayson N Holmbeck
Journal:  J Pediatr Psychol       Date:  2002 Jan-Feb

3.  Religious involvement, coping, social support, and psychological distress in HIV-seropositive African American mothers.

Authors:  Guillermo Prado; Daniel J Feaster; Seth J Schwartz; Indira Abraham Pratt; Lila Smith; José Szapocznik
Journal:  AIDS Behav       Date:  2004-09

4.  Severe adverse life events and depressive symptoms among women with, or at risk for, HIV infection in four cities in the United States of America.

Authors:  J Moore; P Schuman; E Schoenbaum; B Boland; L Solomon; D Smith
Journal:  AIDS       Date:  1999-12-03       Impact factor: 4.177

Review 5.  Psychosocial influences on HIV-1 disease progression: neural, endocrine, and virologic mechanisms.

Authors:  Steve W Cole
Journal:  Psychosom Med       Date:  2008-06       Impact factor: 4.312

6.  The general adaptation syndrome and the diseases of adaptation.

Authors:  H SELYE
Journal:  J Clin Endocrinol Metab       Date:  1946-02       Impact factor: 5.958

7.  Brain oxytocin inhibits the (re)activity of the hypothalamo-pituitary-adrenal axis in male rats: involvement of hypothalamic and limbic brain regions.

Authors:  I D Neumann; S A Krömer; N Toschi; K Ebner
Journal:  Regul Pept       Date:  2000-12-22

8.  A global measure of perceived stress.

Authors:  S Cohen; T Kamarck; R Mermelstein
Journal:  J Health Soc Behav       Date:  1983-12

9.  Posttraumatic growth and HIV disease progression.

Authors:  Joel Milam
Journal:  J Consult Clin Psychol       Date:  2006-10

10.  Relation of lifetime trauma and depressive symptoms to mortality in HIV.

Authors:  Jane Leserman; Brian Wells Pence; Kathryn Whetten; Michael J Mugavero; Nathan M Thielman; Marvin S Swartz; Dalene Stangl
Journal:  Am J Psychiatry       Date:  2007-11       Impact factor: 18.112

View more
  15 in total

1.  Psychosocial and Neurohormonal Predictors of HIV Disease Progression (CD4 Cells and Viral Load): A 4 Year Prospective Study.

Authors:  G Ironson; C O'Cleirigh; M Kumar; L Kaplan; E Balbin; C B Kelsch; M A Fletcher; N Schneiderman
Journal:  AIDS Behav       Date:  2015-08

2.  Oxytocin administration attenuates atherosclerosis and inflammation in Watanabe Heritable Hyperlipidemic rabbits.

Authors:  Angela Szeto; Maria A Rossetti; Armando J Mendez; Crystal M Noller; Edward E Herderick; Julie A Gonzales; Neil Schneiderman; Philip M McCabe
Journal:  Psychoneuroendocrinology       Date:  2012-09-19       Impact factor: 4.905

3.  Oxytocin, social support, and sleep quality in low-income minority women living with HIV.

Authors:  Erin M Fekete; Julia Seay; Michael H Antoni; Armando J Mendez; Mary Ann Fletcher; Angela Szeto; Neil Schneiderman
Journal:  Behav Sleep Med       Date:  2013-06-25       Impact factor: 2.964

Review 4.  Salubrious effects of oxytocin on social stress-induced deficits.

Authors:  Adam S Smith; Zuoxin Wang
Journal:  Horm Behav       Date:  2011-12-08       Impact factor: 3.587

5.  The Association Between Peripheral Oxytocin Levels and Depressive Symptoms in People With HIV.

Authors:  Destin D Shortell; Leah H Rubin; Aidan J Murphy; Ronald A Cohen; Eric C Porges
Journal:  Psychosom Med       Date:  2022-08-16       Impact factor: 3.864

Review 6.  Through the Looking-Glass: Psychoneuroimmunology and the Microbiome-Gut-Brain Axis in the Modern Antiretroviral Therapy Era.

Authors:  Adam W Carrico; Emily M Cherenack; Leah H Rubin; Roger McIntosh; Delaram Ghanooni; Jennifer V Chavez; Nichole R Klatt; Robert H Paul
Journal:  Psychosom Med       Date:  2022-08-28       Impact factor: 3.864

7.  Resilience and HIV Treatment Outcomes Among Women Living with HIV in the United States: A Mixed-Methods Analysis.

Authors:  Faith E Fletcher; Nicholas R Sherwood; Whitney S Rice; Ibrahim Yigit; Shericia N Ross; Tracey E Wilson; Sheri D Weiser; Mallory O Johnson; Mirjam-Colette Kempf; Deborah Konkle-Parker; Gina Wingood; Janet M Turan; Bulent Turan
Journal:  AIDS Patient Care STDS       Date:  2020-08       Impact factor: 5.078

Review 8.  HIV and the Pituitary Gland: Clinical and Biochemical Presentations.

Authors:  Joyce Youssef; Rohan Sadera; Dushyant Mital; Mohamed H Ahmed
Journal:  J Lab Physicians       Date:  2021-05-19

Review 9.  Mini-review: Elucidating the psychological, physical, and sex-based interactions between HIV infection and stress.

Authors:  Hannah Stadtler; Gladys Shaw; Gretchen N Neigh
Journal:  Neurosci Lett       Date:  2021-02-01       Impact factor: 3.197

10.  HIV-1 Tat and morphine decrease murine inter-male social interactions and associated oxytocin levels in the prefrontal cortex, amygdala, and hypothalamic paraventricular nucleus.

Authors:  Sara R Nass; Arianna R S Lark; Yun K Hahn; Virginia D McLane; Therese M Ihrig; Liangru Contois; T Celeste Napier; Pamela E Knapp; Kurt F Hauser
Journal:  Horm Behav       Date:  2021-06-23       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.